Over the last 7 days, the Biotech industry has dropped 2.2%, driven by a pullback from Vertex Pharmaceuticals of 7.9%. In contrast, BeiGene has gained 13%. In the past year, the industry has gained 14%. Looking forward, earnings are forecast to grow by 29% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 10 Aug 2024 | US$1.2t | US$166.7b | -US$32,150,549,450.80 | 23.9x | -36.2x | 7x |
Mon, 08 Jul 2024 | US$1.1t | US$164.5b | -US$28,073,537,735.64 | 27.9x | -40.3x | 6.9x |
Wed, 05 Jun 2024 | US$1.1t | US$164.6b | -US$26,652,225,135.77 | 27.8x | -42.5x | 6.9x |
Fri, 03 May 2024 | US$1.1t | US$163.6b | -US$26,775,356,164.78 | 24.8x | -41x | 6.7x |
Sun, 31 Mar 2024 | US$1.2t | US$164.4b | -US$23,602,941,195.66 | 21.6x | -50x | 7.2x |
Tue, 27 Feb 2024 | US$1.2t | US$166.9b | -US$21,602,631,007.37 | 13.5x | -55.1x | 7.1x |
Thu, 25 Jan 2024 | US$1.4t | US$204.7b | -US$22,524,950,232.00 | 18.2x | -63.9x | 7x |
Sat, 23 Dec 2023 | US$1.4t | US$204.9b | -US$22,145,415,775.00 | 19.4x | -61.9x | 6.7x |
Mon, 20 Nov 2023 | US$1.2t | US$204.7b | -US$22,041,460,760.00 | 18.1x | -55.3x | 6x |
Wed, 18 Oct 2023 | US$1.3t | US$207.4b | -US$13,066,450,907.00 | 17.3x | -97.1x | 6.1x |
Fri, 15 Sep 2023 | US$1.3t | US$207.5b | -US$12,636,400,679.00 | 17.6x | -101.2x | 6.2x |
Sun, 13 Aug 2023 | US$1.3t | US$207.7b | -US$12,540,100,481.00 | 17.1x | -102.7x | 6.2x |
Tue, 11 Jul 2023 | US$1.1t | US$186.4b | -US$16,008,439,670.00 | 13.2x | -70x | 6x |
Thu, 08 Jun 2023 | US$1.1t | US$186.0b | -US$16,014,822,818.00 | 11.7x | -71.2x | 6.1x |
Sat, 06 May 2023 | US$1.2t | US$192.6b | -US$12,088,374,569.00 | 15.6x | -97.1x | 6.1x |
Mon, 03 Apr 2023 | US$1.2t | US$217.0b | -US$6,024,358,980.00 | 14.3x | -192.4x | 5.3x |
Wed, 01 Mar 2023 | US$1.1t | US$199.6b | -US$4,168,872,201.00 | 15.4x | -271.3x | 5.7x |
Fri, 27 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.8x | 660.1x | 5.7x |
Sun, 25 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.5x | 703.1x | 5.7x |
Tue, 22 Nov 2022 | US$1.1t | US$202.1b | US$1.2b | 14.7x | 915.5x | 5.5x |
Thu, 20 Oct 2022 | US$1.0t | US$206.1b | US$5.4b | 15.6x | 191.2x | 5x |
Sat, 17 Sep 2022 | US$1.1t | US$206.6b | US$5.8b | 14.7x | 184.5x | 5.2x |
Mon, 15 Aug 2022 | US$1.1t | US$206.8b | US$7.3b | 15.9x | 154.7x | 5.4x |
Wed, 13 Jul 2022 | US$1.1t | US$211.3b | US$10.7b | 17.2x | 101.6x | 5.1x |
Fri, 10 Jun 2022 | US$993.8b | US$212.7b | US$11.2b | 15.5x | 88.5x | 4.7x |
Sun, 08 May 2022 | US$989.8b | US$207.7b | US$9.7b | 15.5x | 101.8x | 4.8x |
Tue, 05 Apr 2022 | US$1.3t | US$227.0b | US$14.5b | 18.9x | 90.5x | 5.8x |
Thu, 03 Mar 2022 | US$1.2t | US$222.6b | US$8.8b | 19.9x | 140.7x | 5.6x |
Sat, 29 Jan 2022 | US$1.2t | US$212.2b | US$2.5b | 23x | 492x | 5.8x |
Mon, 27 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 26.1x | 522.3x | 6.8x |
Wed, 24 Nov 2021 | US$1.4t | US$211.9b | US$3.2b | 26.4x | 446.8x | 6.8x |
Fri, 22 Oct 2021 | US$1.5t | US$195.8b | -US$3,119,382,838.00 | 25.1x | -477.1x | 7.6x |
Sun, 19 Sep 2021 | US$1.6t | US$196.3b | -US$2,228,427,647.00 | 25.6x | -715.8x | 8.1x |
Tue, 17 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.8x | -941.6x | 7.9x |
-941.6x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -2.33% | |
Healthcare | -1.30% | |
Biotech | -2.22% | |
Biotech | -2.22% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals | US$1.13k | 4.5% +US$5.3b | 40.2% | PE28.3x | |
BGNE BeiGene | US$182.76 | 12.0% +US$2.1b | -7.5% | PS6.3x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
NTRA Natera | US$114.57 | 15.0% +US$1.8b | 103.8% | PS10.3x | |
ABBV AbbVie | US$189.93 | 0.3% +US$1.2b | 24.8% | PE63.3x |